Alpa Laboratories Ltd

NSE: ALPA · BSE: 532878 · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹58.00
Market cap: ₹122.0 Cr
Revenue (annual): ₹105.8 Cr
Net profit (annual): ₹14.13 Cr
P/E (TTM): 34.9×Sector 47.4×
Promoter holding: 57.19%+0.00% QoQ
FII holding: 0.35%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 7 Financial Results 3 Board Meeting Date 2 Results Correction 1 Price Movement Clarification 1 Other Announcement 1 Merger & Restructuring 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 Jul 2026 18:09 IST BSE

Merger & Restructuring

Alpa Laboratories Merger & Restructuring

Alpa Laboratories Ltd. has approved exploring the incorporation of an overseas entity in Nigeria, 'Alpa Biopharm Limited,' in partnership with Blueseal Pharmaceuticals Limited. This is in-principle only.

Read the filing ↗